Valuation: Ipca Laboratories Limited

Capitalization 379B 4.12B 3.56B 3.21B 3.08B 5.62B 5.88B 37.95B 15.21B 182B 15.48B 15.15B 650B P/E ratio 2026 *
33.6x
P/E ratio 2027 * 27.5x
Enterprise value 394B 4.29B 3.7B 3.34B 3.2B 5.84B 6.12B 39.48B 15.82B 189B 16.11B 15.76B 676B EV / Sales 2026 *
4.07x
EV / Sales 2027 * 3.59x
Free-Float
52.38%
Yield 2026 *
0.35%
Yield 2027 * 0.39%
1 day-0.45%
1 week-2.27%
Current month-2.27%
1 month+5.47%
3 months+2.41%
6 months+11.93%
Current year+5.31%
1 week 1,461.3
Extreme 1461.3
1,525
1 month 1,403
Extreme 1403
1,547.4
Current year 1,391.8
Extreme 1391.8
1,582.6
1 year 1,168.2
Extreme 1168.2
1,595
3 years 669.8
Extreme 669.8
1,755.9
5 years 669.8
Extreme 669.8
1,755.9
10 years 200
Extreme 200
1,755.9
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2023
Chief Executive Officer 70 01/04/2023
Chief Tech/Sci/R&D Officer 52 16/10/2023
Director TitleAgeSince
Chairman 79 05/07/2012
Director/Board Member 53 11/11/2008
Director/Board Member 70 01/08/1994
Change 5d. change 1-year change 3-years change Capi.($)
-0.45%-2.27%+12.08%+86.68% 4.12B
+0.72%-5.86%+13.89%+218.81% 885B
+0.32%-3.23%+44.22%+56.01% 579B
-0.96%-0.85%+7.38%+50.47% 407B
-2.93%-7.03%+11.14%+27.55% 350B
-1.25%-5.55%+22.14%+55.83% 302B
-1.85%-6.70%+20.11%+33.64% 301B
-0.24%-6.49%+22.33%+4.06% 286B
+0.53%-4.80%+13.75%+61.56% 199B
-0.83%-3.37%+22.59%+79.29% 179B
Average -0.69%-4.45%+18.96%+67.39% 349.29B
Weighted average by Cap. -0.47%-4.59%+20.26%+89.09%

Financials

2026 *2027 *
Net sales 96.91B 1.05B 909M 821M 788M 1.44B 1.5B 9.7B 3.89B 46.48B 3.96B 3.87B 166B 108B 1.17B 1.01B 914M 877M 1.6B 1.67B 10.81B 4.33B 51.78B 4.41B 4.32B 185B
Net income 11.21B 122M 105M 94.92M 91.08M 166M 174M 1.12B 450M 5.37B 458M 448M 19.22B 13.85B 151M 130M 117M 113M 205M 215M 1.39B 555M 6.64B 566M 553M 23.75B
Net Debt 15.28B 166M 143M 129M 124M 226M 237M 1.53B 613M 7.33B 624M 611M 26.2B 8.74B 95.07M 81.97M 74M 71M 129M 135M 875M 350M 4.19B 357M 349M 14.98B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The products of the Company are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing API’s and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Pharma Nigeria Ltd., Trophic Wellness Pvt. Ltd.
Employees
16,778
Date Price Change Volume
06/03/26 1,494.20 -0.45% 45,541
05/03/26 1,500.90 +1.73% 61,774
04/03/26 1,475.40 -2.49% 87,330
02/03/26 1,513.00 -1.04% 115,864
27/02/26 1,528.90 +0.40% 191,057
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,494.20INR
Average target price
1,644.78INR
Spread / Average Target
+10.08%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. IPCALAB Stock